Text size With production help from Roche Holding, Regeneron plans to have doses for 80,000 patients ready by the end of November. Michael Nagle/Bloomberg Covid-19 patients hoping to avoid the hospital now have a second antibody treatment available to them. This past weekend, Regeneron Pharmaceuticals got an emergency-use authorization from […]
Regeneron
Overnight Health Care: Regeneron asks for emergency authorization of coronavirus treatment Trump received | McConnell says he hasn’t visited White House in two months due to coronavirus | Employer-sponsored health insurance premiums rise 4 percent
Welcome to Thursday’s Overnight Health Care. Regeneron filed for emergency authorization of its antibody COVID-19 treatment drug, just hours after President TrumpDonald John TrumpFive takeaways from the vice presidential debate Harris accuses Trump of promoting voter suppression Pence targets Biden over ISIS hostages, brings family of executed aid worker to […]
Trump’s Regeneron Treatment Is a Tangled Ethical Mess
Text size Michael Nagle/Bloomberg President Donald Trump is illustrating the ethical perils of the “compassionate use” of unapproved medical products in real time. The president’s use of an experimental drug outside of a clinical trial, and the company’s offer of the product to the president’s political rival, raise questions about […]
Trump’s Use of Regeneron Covid Treatment Will Help It Become a Big Seller, Say Analysts
Text size The president’s surprising use of Regeneron’s experimental treatment for Covid-19 could boost chances that the REGN-COV2 product will get an emergency-use authorization from the FDA. Michael Nagle/Bloomberg Add Regeneron Pharmaceuticals ’ antibody cocktail to the list of product endorsements by President Donald Trump. The president’s surprising use of […]
Brazil President Bolsonaro tests positive; biotechs Novavax, Regeneron say drugs almost ready
Brazil President Jair Bolsonaro said Tuesday that he has tested positive for COVID-19, and the U.S. coronavirus death toll has surpassed 130,000. But two U.S. pharmaceutical companies say they are closing in on drugs that could treat or even prevent COVID-19 within a few months. A $450 million federal contract awarded Regeneron Pharmaceuticals […]